S. Kudo et al., Phenacetin deacetylase activity in human liver microsomes: Distribution, kinetics, and chemical inhibition and stimulation, J PHARM EXP, 294(1), 2000, pp. 80-87
Citations number
38
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Microsomal and cytosolic phenacetin deacetylase activities were examined in
human liver and kidneys. Kinetic properties of the activities were also st
udied in human liver microsomes. Phenacetin deacetylase activity was predom
inantly localized in the liver microsomal fraction. The specific activities
of phenacetin deacetylation in liver cytosol and in kidney microsomes and
cytosol were all less than 5% of that in liver microsomes. In human liver m
icrosomes, Eadie-Hofstee plots for phenacetin deacetylation were monophasic
, indicating a single-enzyme catalytic reaction. The Michaelis-Menten param
eters, K-m and V-max, for the deacetylation were 4.7 mM and 5.54 nmol/min/m
g of protein, respectively. The intrinsic clearance, calculated as V-max/K-
m, was 1.18 ml/min/mg of protein. Although the organo-phosphate bis(4-nitro
phenyl) phosphoric acid markedly inhibited the reaction in human liver micr
osomes, the activity has a tolerance to the treatment of phenylmethylsulfon
yl fluoride, a serine hydrolase inhibitor. Prazosin, a peripheral alpha(1)-
adrenergic antagonist, noncompetitively inhibited the phenacetin deacetylat
ion with a K-i value of 19.0 mu M. Flutamide, a nonsteroidal androgen recep
tor antagonist, stimulated the activity by up to 349%. This increase was ac
companied by a decrease in the K-m value and no change in the V-max value,
resulting in an increase in the intrinsic clearance by up to 700% of the co
ntrol. These results suggest that the phenacetin deacetylase localized in h
uman liver microsomes has not only a catalytic site but also a negative and
/or positive modulation site or sites.